Position in ORIC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,822,450
-$12,309,630 QoQ
Shares Held
2,015,000
-25.2% QoQ
Ownership
1.94%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#20
of 179 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. ORIC ranks #42 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in ORIC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,822,450 | 2,015,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $34,132,080 | 2,693,929 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,789,564 | 3,641,756 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,701,072 | 3,641,756 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,127,702 | 899,281 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,906,000 | 700,000 | Shares | Defined | 2025-05-15 | |
| 2024-06-30 | $2,029,797 | 287,100 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,947,625 | 287,100 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,811,305 | 522,968 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,406,691 | 893,668 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,067,311 | 1,168,468 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,834,467 | 1,374,468 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,468,575 | 1,607,568 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,680,217 | 2,087,568 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,352,304 | 2,087,568 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,147,613 | 2,087,568 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,362,337 | 2,337,574 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $48,878,672 | 2,337,574 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,351,684 | 2,337,574 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $57,270,563 | 2,337,574 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $98,908,582 | 2,921,967 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $73,078,394 | 2,921,967 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $98,557,946 | 2,921,967 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||